Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

9.24
Delayed Data
As of Jun 30
 -0.19 / -2.01%
Today’s Change
4.50
Today|||52-Week Range
11.69
+37.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues5.3M24.2M5.9M8.1M
 
 
 
 
 
Depreciation And Amortization456.5K497.8K526.9K597.4K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.0M20.0M19.9M23.0M
 
 
 
 
 
Research And Development16.7M16.1M15.6M18.2M
 
 
 
 
 
Total Operating Expenses21.4M20.5M20.5M23.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M3.7M-14.5M-15.5M
 
 
 
 
 
Extraordinary Credit8.8M0.000.000.00
 
 
Extraordinary Charge---140.2K-3.5M-406.2K
 
 
 
 
Other Expenses1.1M215.0K-194.5K7.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M3.8M-18.3M-8.0M
 
 
 
 
 
Income Taxes0.00-1.8M-308.5K0.00
 
 
 
Minority Interest-85.9K0.000.000.00
 
 
Net Income-6.2M5.6M-18.0M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.7M72.0M72.2M72.2M
 
 
 
 
 
Shares To Calculate EPS Diluted67.8M74.0M72.2M72.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09$0.07-$0.25-$0.11
 
 
 
 
 
EPS Diluted-$0.09$0.07-$0.25-$0.11